本研究的主要目的是评估内皮祖细胞来源的外泌体(EPC-Exo)对大鼠球囊损伤引起的新内膜形成的影响。此外,该研究旨在调查EPC-Exo促进增殖的潜力,迁移,血管内皮细胞(VECs)的体外抗凋亡作用。负责这些观察到的影响的潜在机制也将被彻底探索和分析。从Sprague-Dawley(SD)大鼠无菌分离内皮祖细胞(EPCs),并在完全培养基中培养。然后使用免疫荧光和流式细胞术鉴定细胞。EPC-Exo被分离,并通过蛋白质印迹确认身份,透射电子显微镜,和纳米粒子分析。通过苏木精和伊红(H&E)染色检测EPC-Exo对大鼠颈动脉球囊损伤(BI)的影响,ELISA,免疫组织化学,免疫荧光,蛋白质印迹和qPCR。应用LPS树立VECs氧化毁伤模子。通过测定血管内皮细胞的增殖,探讨EPC-Exo修复损伤血管内皮细胞的机制,迁移,和VEC的管功能,肌动蛋白细胞骨架染色,TUNEL染色,免疫荧光,蛋白质印迹和qPCR。在体内,EPC-Exo对颈动脉损伤后新生内膜的形成有抑制作用,降低炎症因子水平,包括TNF-α和IL-6。此外,EPC-Exo下调受损血管壁上粘附分子的表达。值得注意的是,EPC-Exo可以粘附到受伤的血管区域,促进内皮功能增强,抑制血管内皮增生,它们调节与细胞凋亡相关的蛋白质和基因的表达,包括B细胞淋巴瘤-2(Bcl2),Bcl2相关x(Bax),和Caspase-3。体外,实验进一步证实EPC-Exo处理显著增强了细胞增殖,迁移,和VEC的管形成。此外,EPC-Exo可有效减弱脂多糖(LPS)诱导的VECs凋亡,并调节Bcl2/Bax/Caspase-3信号通路。这项研究表明,源自EPCs的外泌体具有抑制BI后颈动脉内膜过度增生的能力,促进内膜损伤区域内皮细胞的修复,增强内皮功能。潜在的机制涉及抑制炎症和抗凋亡作用。这种抗凋亡作用的基本机制涉及Bcl2/Bax/Caspase-3信号通路的调节。
The main objective of this study is to evaluate the influence of exosomes derived from endothelial progenitor cells (EPC-Exo) on neointimal formation induced by balloon injury in rats. Furthermore, the study aims to investigate the potential of EPC-Exo to promote proliferation, migration, and anti-apoptotic effects of vascular endothelial cells (VECs) in vitro. The underlying mechanisms responsible for these observed effects will also be thoroughly explored and analyzed. Endothelial progenitor cells (EPCs) was isolated aseptically from Sprague-Dawley (SD) rats and cultured in complete medium. The cells were then identified using immunofluorescence and flow cytometry. The EPC-Exo were isolated and confirmed the identities by western-blot, transmission electron microscope, and nanoparticle analysis. The effects of EPC-Exo on the rat carotid artery balloon injury (BI) were detected by hematoxylin and eosin (H&E) staining, ELISA, immunohistochemistry, immunofluorescence, western-blot and qPCR. LPS was used to establish an oxidative damage model of VECs. The mechanism of EPC-Exo repairing injured vascular endothelial cells was detected by measuring the proliferation, migration, and tube function of VECs, actin cytoskeleton staining, TUNEL staining, immunofluorescence, western-blot and qPCR. In vivo, EPC-Exo exhibit inhibitory effects on neointima formation following carotid artery injury and reduce the levels of inflammatory factors, including TNF-α and IL-6. Additionally, EPC-Exo downregulate the expression of adhesion molecules on the injured vascular wall. Notably, EPC-Exo can adhere to the injured vascular area, promoting enhanced endothelial function and inhibiting vascular endothelial hyperplasia Moreover, they regulate the expression of proteins and genes associated with apoptosis, including B-cell lymphoma-2 (Bcl2), Bcl2-associated x (Bax), and Caspase-3. In vitro, experiments further confirmed that EPC-Exo treatment significantly enhances the proliferation, migration, and tube formation of VECs. Furthermore, EPC-Exo effectively attenuate lipopolysaccharides (LPS)-induced apoptosis of VECs and regulate the Bcl2/Bax/Caspase-3 signaling pathway. This study demonstrates that exosomes derived from EPCs have the ability to inhibit excessive carotid intimal hyperplasia after BI, promote the repair of endothelial cells in the area of intimal injury, and enhance endothelial function. The underlying mechanism involves the suppression of inflammation and anti-apoptotic effects. The fundamental mechanism for this anti-apoptotic effect involves the regulation of the Bcl2/Bax/Caspase-3 signaling pathway.